Apart from ageing, APOE4 is also the most significant established risk factor for late-onset AD, increasing the likelihood of disease by 17% and 43% for hetero- and homozygosity respectively and decreasing age of onset (41). This evidence concerns the gene APOE and Alzheimer disease.